These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9565719)

  • 1. Sociodemographic predictors of response to antidepressant treatment.
    Spillmann M; Borus JS; Davidson KG; Worthington JJ; Tedlow JR; Fava M
    Int J Psychiatry Med; 1997; 27(2):129-36. PubMed ID: 9565719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social adjustment does not predict depressive relapse during continuation fluoxetine therapy.
    Nierenberg AA; Grossbard SJ; Fava M; Rosenbaum JF
    J Affect Disord; 1995 May; 34(2):73-7. PubMed ID: 7665807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual symptoms in depressed patients who respond acutely to fluoxetine.
    Nierenberg AA; Keefe BR; Leslie VC; Alpert JE; Pava JA; Worthington JJ; Rosenbaum JF; Fava M
    J Clin Psychiatry; 1999 Apr; 60(4):221-5. PubMed ID: 10221281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder.
    Sonawalla SB; Papakostas GI; Petersen TJ; Yeung AS; Smith MM; Sickinger AH; Gordon J; Israel JA; Tedlow JR; Lamon-Fava S; Fava M
    Psychosomatics; 2002; 43(4):310-6. PubMed ID: 12189257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome definitions and predictors in depression.
    Tedlow J; Fava M; Uebelacker L; Nierenberg AA; Alpert JE; Rosenbaum J
    Psychother Psychosom; 1998; 67(4-5):266-70. PubMed ID: 9693355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone.
    Onder E; Tural U
    J Affect Disord; 2003 Sep; 76(1-3):223-7. PubMed ID: 12943952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine.
    Papakostas GI; Petersen T; Denninger JW; Tossani E; Pava JA; Alpert JE; Nierenberg AA; Fava M
    J Clin Psychopharmacol; 2004 Oct; 24(5):507-11. PubMed ID: 15349006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting response to fluoxetine in geriatric patients with major depression.
    Koran LM; Hamilton SH; Hertzman M; Meyers BS; Halaris AE; Tollefson GD; Downs JM; Folks DG; Jeste DV; Lazarus LW
    J Clin Psychopharmacol; 1995 Dec; 15(6):421-7. PubMed ID: 8748431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of personality disorders to treatment outcome in depressed outpatients.
    Mulder RT; Joyce PR; Luty SE
    J Clin Psychiatry; 2003 Mar; 64(3):259-64. PubMed ID: 12716266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode.
    Jangid P; Malik P; Singh P; Sharma M; Gulia AK
    Asian J Psychiatr; 2013 Feb; 6(1):29-34. PubMed ID: 23380314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder.
    Papakostas GI; Petersen T; Homberger CH; Green CH; Smith J; Alpert JE; Fava M
    Ann Clin Psychiatry; 2007; 19(1):5-8. PubMed ID: 17453655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.
    Holland JC; Romano SJ; Heiligenstein JH; Tepner RG; Wilson MG
    Psychooncology; 1998; 7(4):291-300. PubMed ID: 9741068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual functioning in patients with recurrent major depressive disorder enrolled in the PREVENT study.
    Gelenberg AJ; Dunner DL; Rothschild AJ; Pedersen R; Dorries KM; Ninan PT
    J Nerv Ment Dis; 2013 Apr; 201(4):266-73. PubMed ID: 23538970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.